Epigenetic Modulation of Class-switch DNA Recombination to IgA by miR- 146a through Downregulation of Smad2, Smad3 and Smad4

نویسندگان

چکیده

Abstract IgA is the predominant isotype at intestinal mucosae, where it plays a critical role in homeostasis and first line of immune protection. Class-switch DNA recombination (CSR) to directed by TGF-b which induces activation Smad2 Smad3 transcription factors. Activated Smad2/Smad3 dimers are recruited with Smad4 IgH α locus Iα promoter activate germline Iα-Cα transcription, step CSR IgA. Epigenetic factors, such as microRNAs, regulate cells and, we have shown, modulate antibody response B cell- intrinsic fashion. We found that miR-146a targets Smad2, mRNA 3’UTRs, keeps check resting cells. Enforced expression aborted decreasing Smad levels. Induction IgA, TGF-b, downregulated cell miR-146a, thereby reversing silencing Smad4, which, once expressed, led recruitment for transcription. miR- 146a−/− mice significantly increased circulating levels total but not IgM, IgG or IgE, heightened specific OVA. In miR-146a−/− mice, this was associated IgA+ amounts fecal free bacteria-bound kidney deposition nephropathy. The cell-intrinsic repression confirmed −/− vitro vivo mixed bone marrow μMT/miR-146a−/− chimeric mice. Thus, inhibition expression, an important modulation response. Supported NIH grants AI 079705, 105813, AAI 167416 LRA grant 641363 PC.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Epigenetic control of epileptogenesis by miR-146a

Treatments for epilepsy, a multi-etiology brain disorder affecting over 50 million people worldwide, are so far limited to drugs which provide mere symptomatic control of seizures, have many adverse effects and are ineffective in up to 40% of patients [1]. These considerations urge on the development of therapies with disease-modifying properties targeting the key pathogenic mechanisms generati...

متن کامل

SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer.

Activation of the canonical TGF-β signaling pathway provides growth inhibitory signals in the normal intestinal epithelium. Colorectal cancers (CRCs) frequently harbor somatic mutations in the pathway members TGFBR2 and SMAD4, but to what extent mutations in SMAD2 or SMAD3 contribute to tumorigenesis is unclear. A cohort of 744 primary CRCs and 36 CRC cell lines were sequenced for SMAD4, SMAD2,...

متن کامل

Epigenetic Codes Programing Class Switch Recombination

Class switch recombination imparts B cells with a fitness-associated adaptive -advantage during a humoral immune response by using a precision-tailored DNA excision and ligation process to swap the default constant region gene of the antibody with a new one that has unique effector functions. This secondary diversification of the antibody repertoire is a hallmark of the adaptability of B cells ...

متن کامل

TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4 includes activins and bone morphogenetic proteins

includes activins and bone morphogenetic proteins Atsuhito Nakao1, Takeshi Imamura2, (BMPs). TGF-β superfamily members induce a multitude Serhiy Souchelnytskyi, of effects and have been shown to control proliferation, Masahiro Kawabata2, Akira Ishisaki, differentiation, migration and apoptosis of many different Eiichi Oeda2, Kiyoshi Tamaki, cell types (Roberts and Sporn, 1993). They act via lig...

متن کامل

Epigenetic tethering of AID to the donor switch region during immunoglobulin class switch recombination

Immunoglobulin class switch recombination (CSR) is initiated by double-stranded DNA breaks (DSBs) in switch regions triggered by activation-induced cytidine deaminase (AID). Although CSR correlates with epigenetic modifications at the IgH locus, the relationship between these modifications and AID remains unknown. In this study, we show that during CSR, AID forms a complex with KAP1 (KRAB domai...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Immunology

سال: 2022

ISSN: ['1550-6606', '0022-1767']

DOI: https://doi.org/10.4049/jimmunol.208.supp.112.19